http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02111721-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
filingDate 1988-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9808a972c640f6f3f3f97e88edba91d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9afeb75f277bbc02d231eed1ea94ef7c
publicationDate 1990-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H02111721-A
titleOfInvention Remedy for nephritis
abstract PURPOSE: To obtain a remedy for nephritis, especially useful for treating glomerulonephritis and membranous nephritis, showing inhibitory action on crisis of nephritis, especially Hyman nephritis, having low toxicity and low side effects and excellent safety, comprising a specific compound having immunomodulating action as an active ingredient. n CONSTITUTION: A remedy for nephritis containing 6-p-chlorobenzyl-5H2,3,6,7- tetrahydro-5,7-dioxothiazolo(3,2-a)pyrimidine shown by formula I as an active ingredient. The active ingredient is blended with a carrier and an auxiliary, pharmaceutically manufactured into a dosage form for oral administration such as tablet, capsule, powder or granule or suppository, solution, ointment or injection for intravenous injection, intramuscular injection, etc., and oral administration is preferable with respect to simplicity of use and safety. The active ingredient is suspended in 5% solution of gum arabic to give a suspension, which is administered once a day or five times a week by sensitizing action of Fx1A antigen and rise in protein in urine and serum anti-Fx1A antibody can be improved. n COPYRIGHT: (C)1990,JPO&Japio
priorityDate 1988-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID128798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228248970
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID138043
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID138043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415827122

Total number of triples: 19.